Collaborating with traditional healers to deliver point-of-care HIV tests to individuals in rural Uganda quadrupled testing rates compared with standard referrals to HIV clinics.
Weill Cornell Medicine has received a $2 million grant from the National Institutes of Health (NIH) to participate in a multicenter clinical initiative focused on understanding and treating cirrhosis, scarring of the liver that leads to the organ’s failure and increases the risk of liver cancer.
Lymphomas can turbo-charge their ability to proliferate by crowding growth-supporting enzymes into highly concentrated compartments within tumor cells, according to a study led by researchers at Weill Cornell Medicine.
More than a decade after the Vietnam War ended, a group of American veterans came together to form a humanitarian nonprofit called Vets With a Mission. Their goal: to help rebuild the country where they’d witnessed so much destruction— and to make peace with their own experiences there.
The effectiveness of fecal microbiota transplantation (FMT) in treating ulcerative colitis depends on a small set of beneficial bacterial strains, suggests a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Dr. Larissa V. Rodríguez, a distinguished physician-scientist and urologic surgeon who specializes in female pelvic medicine and reconstructive surgery, has been named chair of the Department of Urology at Weill Cornell Medicine and urologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center
Apart from being a neurosurgery physician assistant at NewYork- Presbyterian/Weill Cornell Medical Center, my primary responsibility for several years was taking care of my father, Eddie, managing his medications and the symptoms of his Parkinson’s disease. It was a difficult and trying few years for my family, but mostly for my dad, and in March 2019 he passed away.
A brain circuit that works as a “brake” on binge alcohol drinking may help explain male-female differences in vulnerability to alcohol use disorders, according to a preclinical study led by scientists at Weill Cornell Medicine.
COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Over the past few decades, HIV treatment has advanced remarkably: simply by taking one pill each day, most patients can suppress the virus to the point where it’s undetectable and can’t be transmitted to someone else. While the therapy— generally a combination of three drugs in a single dose—has markedly slowed the HIV epidemic, it hasn’t stopped it entirely.
A team led by researchers at Weill Cornell Medicine, the New York Genome Center, Harvard Medical School, Massachusetts General Hospital and the Broad Institute of MIT and Harvard has profiled in unprecedented detail thousands of individual cells sampled from patients’ brain tumors.
Depression is the most common mental illness as well as the number one cause of disability among people between the ages of 15 and 44. And for millions of sufferers, antidepressants have literally saved lives that could otherwise have been lost to suicide.
Convalescent plasma did not reduce the risk of intubation or death for hospitalized COVID-19 patients in a large, international clinical trial conducted by Weill Cornell Medicine and NewYork-Presbyterian investigators in collaboration with lead investigators at McMaster University.
With vaccine availability growing in New York City and across the country, attention is increasingly turning to those who remain hesitant to receive it.
Turning off a defense mechanism that protects colorectal cancer tumors from being discovered by immune cells could be a possible strategy for treating the disease.
The master regulator behind the development of antibody-producing cells has been identified in a study by investigators at Weill Cornell Medicine. The findings provide new insight into the inner workings of the immune system and may help understand how tissues develop and how certain cancers arise.
Dr. Julia Cron has been appointed chief and vice chair of the Department of Obstetrics and Gynecology at NewYork-Presbyterian Lower Manhattan Hospital, effective Oct. 1.
